Xact Kapitalforvaltning’s BioTelemetry, Inc. BEAT Stock Holding History

Xact Kapitalforvaltning’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$254K	Hold	6,600	–	–	0.01%	1101
2019 Q4	$306K	Hold	6,600	–	–	0.01%	1235
2019 Q3	$269K	Hold	6,600	–	–	0.01%	1249
2019 Q2	$318K	Hold	6,600	–	–	0.01%	1190
2019 Q1	$413K	Hold	6,600	–	–	0.01%	1038
2018 Q4	$394K	Hold	6,600	–	–	0.01%	1054
2018 Q3	$425K	Hold	6,600	–	–	0.01%	1097
2018 Q2	$297K	Sell	6,600 -200	-3%	-$7.97K	0.01%	1358
2018 Q1	$211K	Buy	+6,800	New	+$224K	﹤0.01%	1465

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Xact Kapitalforvaltning's BEAT Position: Q1 2020 in Review

Xact Kapitalforvaltning held its BioTelemetry, Inc. (BEAT) position steady in Q1 2020 at 6,600 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #1101.

Xact Kapitalforvaltning first reported a position in BEAT in Q1 2018 and has held it in 9 quarters since. The position peaked at $425K in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Xact Kapitalforvaltning held 6,600 shares of BioTelemetry, Inc. worth $254K as of Q1 2020.
Xact Kapitalforvaltning left its BioTelemetry, Inc. share count unchanged in Q1 2020.
BioTelemetry, Inc. made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1101 holding.
Xact Kapitalforvaltning first reported a position in BioTelemetry, Inc. in Q1 2018 and has held it in 9 quarters since.
Xact Kapitalforvaltning's BioTelemetry, Inc. position peaked at $425K in Q3 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.